1. Chemical Proteomics Reveals that the Anticancer Drug Everolimus Affects the Ubiquitin–Proteasome System
    Anna A. Lobas et al, 2024, ACS Pharmacology & Translational Science CrossRef
  2. Anticancer activity and computational modeling of ternary copper (II) complexes with 3-indolecarboxylic acid and 1,10-phenanthroline
    Zhen Zhang et al, 2016, International Journal of Oncology CrossRef
  3. Redox dynamics of manganese as a mitochondrial life-death switch
    Matthew Ryan Smith et al, 2017, Biochemical and Biophysical Research Communications CrossRef
  4. Endoplasmic reticulum stress: an arising target for metal-based anticancer agents
    A. Paden King et al, 2020, Chemical Society Reviews CrossRef
  5. Pyrazole derivatives of pyridine and naphthyridine as proapoptotic agents in cervical and breast cancer cells
    Rima D. Alharthy et al, 2023, Scientific Reports CrossRef
  6. In Vitro DNA-Binding, Anti-Oxidant and Anticancer Activity of Indole-2-Carboxylic Acid Dinuclear Copper(II) Complexes
    Xiangcong Wang et al, 2017, Molecules CrossRef
  7. Ceftazidime and cefepime antagonize 5-fluorouracil’s effect in colon cancer cells
    Christina Pfab et al, 2022, BMC Cancer CrossRef
  8. Bis(pyridazine-5-olate-4-carboxylate)manganese hydrate: Synthesis, characterization, and in vitro antitumor activities
    Yi Yang et al, 2017, Inorganic and Nano-Metal Chemistry CrossRef
  9. Synthesis, characterization, and anticancer activity of Schiff bases
    Noor Uddin et al, 2020, Journal of Biomolecular Structure and Dynamics CrossRef
  10. Transition metal complexes as proteasome inhibitors for cancer treatment
    null Shagufta et al, 2020, Inorganica Chimica Acta CrossRef
  11. Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?
    Christina Pfab et al, 2021, Cancers CrossRef
  12. Complexes of β-lactam antibiotics and their Schiff-base derivatives as a weapon in the fight against bacterial resistance
    Michał Zabiszak et al, 2023, Coordination Chemistry Reviews CrossRef
  13. The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges
    G.R. Tundo et al, 2020, Pharmacology & Therapeutics CrossRef